Tefiducky8 (Talk | contribs) |
Tefiducky8 (Talk | contribs) |
||
Line 1,442: | Line 1,442: | ||
document.getElementById("phase_1_main_container").style.display = "none"; | document.getElementById("phase_1_main_container").style.display = "none"; | ||
document.getElementById("phase_3_main_container").style.display = "none"; | document.getElementById("phase_3_main_container").style.display = "none"; | ||
− | document.getElementById("ecuador_footer").style.top = " | + | document.getElementById("ecuador_footer").style.top = "1400px"; |
} | } | ||
if(phase == 3){ | if(phase == 3){ |
Revision as of 10:54, 4 October 2018
PHASE 1 BACTERIAL CELLULOSE
PHASE 2 FUSION PROTEIN CBD-ELP-BMP2
LASTIN-LIKE POLYPEPTIDES
Elastin-like polypeptides
(ELP) are genetically encodable artificial biopolymers. They are elastomeric
proteins formed by a repetitive pentapeptide of Val-Pro-Gly-Xaa-Gly sequence, Xaa can be any
amino acid except proline. [1].
ELPs are thermostable biopolymers
whose properties vary depending on the temperature, pH or ionic strength. They
can pass from a soluble state to an insoluble one and reversibly depending on
their transition temperature (Tt) [2], at temperatures lower than
the Tt ELPs are soluble, but insoluble when the temperature exceeds the Tt.
This property is maintained even when they are fused with other proteins and
has been used in protein purification. The amino acid residues that contain
groups susceptible to ionization result in a polymer with a Tt regulated by
changes in pH, in addition, the substitution of the Xaa
residue allows ELP to be designed with a desired Tt[3].
In biomedicine, ELPs have
applications in the specific drug delivery, in tissue engineering and
regenerative medicine. It has been possible to selectively transport
antineoplastic drugs to pathologically changed tissues, allowing the
polymer-drug conjugates to accumulate in the vicinity of a tumour,
showing a lower toxicity compared to free-running drugs. [1].
In regenerative medicine,
ELPs have been used as scaffolds in tissue regeneration, and have shown
promising results in treatments for articular cartilage damage, where a
hydrogel made of ELP is used, in which it effectively contributed to the production
of a cartilage matrix. Other studies show that ELPs conjugated with polymers
such as polyacrylic acid and polyethyleneimine can strongly influence the
aggregation, morphology and differentiated function of hepatocytes in vitro,
showing the ability to use ELP in the regeneration of liver tissue [1].
In addition, ELPs have shown promising results to be used in the engineering of
ocular surface tissues, and in vascular grafts [4].
SUPER FOLDER GREEN FLUORESCENT PROTEIN
More complete variants of GFP are used as fusion markers and protein
expression reporters, but fused proteins can reduce the yield, yield, and
fluorescence of these GFPs.[1] They
perform the process properly, when expressed alone or when it is fused to
well-folded proteins; In addition, the resistance of GFP is dependent on the
chemistry and thermal denaturation. In this project we will use a GFP
super-folder, which is a variation of the green fluorescent protein (GFP).
Frequently, wild-type GFP is misfolded when expressed in E. coli and when
expressed as fusions with other proteins. Unlike this one, the GFP super-folder
contains 'cycle-3' mutations and the 'enhanced GFP' mutations F64L and S65T[2],
giving it a better tolerance to circular permutation, greater resistance to
chemical denaturing[3] and better folding kinetics. Therefore, it
can be folded correctly even though the fused protein is not well folded. In
2006 it was evidenced through X-ray crystallographic structural analysis, the
presence of a network of five-member ion pairs in the GFP superfolder,
based on its S30R mutation; and thus improving its folding compared to the GFP
reporter.
BONE MORPHOGENETIC PROTEIN
II
The discovery
of BMPs by Urist in 1965 has been a breakthrough in
research that has been shown that the protein is able to stimulate bone
production. Due to these properties, this protein is currently used in various
fields such as Traumatology, Tissue Engineering and orthopedic surgery in which
recombinant human BMP2 (rhBMP2) is used. The implantation of BMP2 in a collagen
sponge induces the formation of new bone and can be used as a treatment for
certain bone defects[4].
Oral surgery
has benefited in particular with the commercialization of this protein, since
the use of BMP2 in absorbable collagen sponges has significantly reduced the
costs of the interventions and the pain suffered by patients with degenerative
disease of the lumbar discotheques.
References
1. Schaerli, Y., Munteanu, A., Gili, M., Cotterell, J., Sharpe, J., & Isalan, M. (2014). A unified design space of synthetic stripe-forming networks. Nature communications, 5, 4905.
2. Pédelacq, J. D., Cabantous, S., Tran, T., Terwilliger, T. C., & Waldo, G. S. (2006). Engineering and characterization of a superfolder green fluorescent protein. Nature biotechnology, 24(1), 79.
3. Tanenbaum, M. E., Gilbert, L. A., Qi, L. S., Weissman, J. S., & Vale, R. D. (2014). A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell, 159(3), 635-646.
4. Francisca Pulido, J. G. (10 de 12 de 2013). Actualidad Médica . Obtenido de BMP-2 in Traumatology. Advances in Tissue Engineering: https://www.actualidadmedica.es/archivo/2013/790/rev01.html
CELLULOSE-BINDING
DOMAINS
Cellulose, the most
abundant biopolymer and biorenewable compound Earth,
is a recalcitrant polysaccharide[1].
Cellulolytic organisms are capable of degrading cellulose which involves
excretion of endo- and exo-glucanases as well as
glucosidases. Structurally, these enzymes are modular, consisting of a
catalytic domain and cellulose-binding domain (CBD), as well as possible
ancillary domains[2]. Because of the modules play generally their
respective role independently, the CBD has been studied to improve the
cellulose degradation as well as to bind other functional proteins. It has been foun that CBD can be found at the N-terminal or at
the C-terminal region of these enzymes[4].
In order to evaluate an
N-terminal and a C-terminal CBD we chose the domain of Clostridium thermocellum cellulosome-scaffolding protein A (cipA) and the domain of Cellulomonas fimi exoglucanase (Cex). We used the CBDcipA because the high affinity among other CBDs reported by the Imperail College London team (2014).
The modules are joined by linkers
that are variable in terms of length and amino acid composition. The length
ranges from a few to up to 150 amino acids whereas the sequences are rich in
proline or/and hydroxyamino acids[3].
Because of the synergistic activity between the catalytic and cellulose-binding
domain is dependent of the length and/or linker sequence, we have used their
respective endogenous linkers[2].
References
1. Guan, H., Gurau, G. & Rogers, R.
(2012). Ionic liquid processing of cellulose. Chemical Society Reviews. Issue 4, 2012
2. Poon, D., Withers, Stephen., and McIntosh, L. (2006). Direct
demonstration of the flexibility of the glycosylated proline-threonine linker
in the Cellulomonas fimi Xylanase Cex through NMR spectroscopic analysis. The Journal of Biological Chemistry 282(3):2091-100.
3. Gilkes, N., Henrissat,
B., Kilburn, D., Miller, R. & Warren, R. (1991). Domains in microbial
beta-1, 4-glycanases: sequence conservation, function, and enzyme families. Microbiology Reviews. 55, 303–315
4. Zhang, M., Wu, Sheng-Cheng., Zhou, W. & Xu, B. (2012). Imaging
and Measuring Single-Molecule Interaction between a Carbohydrate-Binding Module
and Natural Plant Cell Wall Cellulose. The
Journal of Physical Chemistry 116, 9949−9956